458 related articles for article (PubMed ID: 25656654)
1. The role of CD95 and CD95 ligand in cancer.
Peter ME; Hadji A; Murmann AE; Brockway S; Putzbach W; Pattanayak A; Ceppi P
Cell Death Differ; 2015 Apr; 22(4):549-59. PubMed ID: 25656654
[TBL] [Abstract][Full Text] [Related]
2. CD95 signaling in colorectal cancer.
Hoogwater FJ; Steller EJ; Westendorp BF; Borel Rinkes IH; Kranenburg O
Biochim Biophys Acta; 2012 Aug; 1826(1):189-98. PubMed ID: 22498253
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis by IFNgamma in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit.
Bernassola F; Scheuerpflug C; Herr I; Krammer PH; Debatin KM; Melino G
Cell Death Differ; 1999 Jul; 6(7):652-60. PubMed ID: 10453076
[TBL] [Abstract][Full Text] [Related]
4. Mice lacking functional CD95-ligand display reduced proliferation of the intestinal epithelium without gross homeostatic alterations.
Trumpi K; Steller EJ; de Leng WW; Raats DA; Nijman IJ; Morsink FH; Borel Rinkes IH; Kranenburg O
Med Mol Morphol; 2016 Jun; 49(2):110-8. PubMed ID: 26700225
[TBL] [Abstract][Full Text] [Related]
5. Does CD95 have tumor promoting activities?
Peter ME; Legembre P; Barnhart BC
Biochim Biophys Acta; 2005 May; 1755(1):25-36. PubMed ID: 15907590
[TBL] [Abstract][Full Text] [Related]
6. CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation.
Nijkamp MW; Hoogwater FJ; Steller EJ; Westendorp BF; van der Meulen TA; Leenders MW; Borel Rinkes IH; Kranenburg O
J Hepatol; 2010 Dec; 53(6):1069-77. PubMed ID: 20832890
[TBL] [Abstract][Full Text] [Related]
7. DICE: A novel tumor surveillance mechanism-a new therapy for cancer?
Peter ME
Cell Cycle; 2014; 13(9):1373-8. PubMed ID: 24690893
[TBL] [Abstract][Full Text] [Related]
8. The CD95 receptor: apoptosis revisited.
Peter ME; Budd RC; Desbarats J; Hedrick SM; Hueber AO; Newell MK; Owen LB; Pope RM; Tschopp J; Wajant H; Wallach D; Wiltrout RH; Zörnig M; Lynch DH
Cell; 2007 May; 129(3):447-50. PubMed ID: 17482535
[TBL] [Abstract][Full Text] [Related]
9. Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implications.
Strand S; Galle PR
Mol Med Today; 1998 Feb; 4(2):63-8. PubMed ID: 9547792
[TBL] [Abstract][Full Text] [Related]
10. Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo.
Ehl S; Hoffmann-Rohrer U; Nagata S; Hengartner H; Zinkernagel R
J Immunol; 1996 Apr; 156(7):2357-60. PubMed ID: 8786290
[TBL] [Abstract][Full Text] [Related]
11. Lack of proapoptotic activity of soluble CD95 ligand is due to its failure to induce CD95 oligomers.
Jang S; Krammer PH; Salgame P
J Interferon Cytokine Res; 2003 Aug; 23(8):441-7. PubMed ID: 13678432
[TBL] [Abstract][Full Text] [Related]
12. CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells.
Barnhart BC; Legembre P; Pietras E; Bubici C; Franzoso G; Peter ME
EMBO J; 2004 Aug; 23(15):3175-85. PubMed ID: 15272306
[TBL] [Abstract][Full Text] [Related]
13. CD95 signaling in cancer treatment.
De la Rosa AJ; Gomez MA; Morales S; Padillo FJ; Muntane J
Curr Pharm Des; 2014; 20(17):2809-18. PubMed ID: 23944368
[TBL] [Abstract][Full Text] [Related]
14. Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system.
Li-Weber M; Krammer PH
Semin Immunol; 2003 Jun; 15(3):145-57. PubMed ID: 14563113
[TBL] [Abstract][Full Text] [Related]
15. Nonapoptotic functions of Fas/CD95 in the immune response.
Guégan JP; Legembre P
FEBS J; 2018 Mar; 285(5):809-827. PubMed ID: 29032605
[TBL] [Abstract][Full Text] [Related]
16. CD95 and CD95L promote and protect cancer stem cells.
Ceppi P; Hadji A; Kohlhapp FJ; Pattanayak A; Hau A; Liu X; Liu H; Murmann AE; Peter ME
Nat Commun; 2014 Nov; 5():5238. PubMed ID: 25366259
[TBL] [Abstract][Full Text] [Related]
17. The CD95/CD95L pathway is involved in phagocytosis-induced cell death of monocytes and may account for sustained inflammation in neonates.
Gille C; Dreschers S; Leiber A; Lepiorz F; Krusch M; Grosse-Opphoff J; Spring B; Haas M; Urschitz M; Poets CF; Orlikowsky TW
Pediatr Res; 2013 Apr; 73(4 Pt 1):402-8. PubMed ID: 23269121
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD95 and CD95L on astrocytes in the CA1 area of the immature rat hippocampus after hypoxia-ischemia injury.
Kim MJ; Lim HS; Yoo YB; Lee YI; Hahm DH; Lee HJ; Jung KW; Kim JW; Yoe SM; Chung DC; Chang YP
Comp Med; 2007 Dec; 57(6):581-9. PubMed ID: 18246871
[TBL] [Abstract][Full Text] [Related]
19. CD95 ligand expression in dedifferentiated breast cancer.
Müschen M; Moers C; Warskulat U; Niederacher D; Betz B; Even J; Lim A; Josien R; Beckmann MW; Häussinger D
J Pathol; 1999 Nov; 189(3):378-86. PubMed ID: 10547600
[TBL] [Abstract][Full Text] [Related]
20. Induction of murine hepatocyte death by membrane-bound CD95 (Fas/APO-1)-ligand: characterization of an in vitro system.
Schlosser SF; Azzaroli F; Dao T; Hingorani R; Crispe IN; Boyer JL
Hepatology; 2000 Oct; 32(4 Pt 1):779-85. PubMed ID: 11003622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
